Biogen Exits Joint Venture As Samsung Biologics Buys Out Bioepis

Sale Price Of $2.3bn To Be Paid Over Next Two Years

Hand separating puzzle pieces
Biogen announced its decision to sell its stake in January • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business